 |
| | Proven benefits
- Good-to-excellent long-term
pain relief
- Excellent or good pain relief scores (mean 61%) reported in 95% of 429 patients
over
a period of 8-94 months [1]
| |
- 74% of 120 patients benefited from intrathecal
therapy over a period of 0.5-5.7 years.
After a mean follow-up of 3.4 years, 58% of patients reported
reduced pain [2]
|
| |
- 77% of 26 patients reported good-to-excellent
pain relief over an average of 23 months [3] |
- Enhanced performance of activities
of daily living (ADL)
- 50% average improvement in daily functioning in 26 patients [3]
- Substantial increases in ADL; 57% moderate or great increase;
82% some increase [1]
- Quality of life indicators significantly improved in patients with non-malignant
pain 1 year after implants [4]
- 81% of 120 patients were satisfied with therapy received [2]
- High patient satisfaction
- 92% of 120 patients reported improved quality of life [5]
- Reduced side-effects
- Dose can be reduced to as little as 1/300th of the oral dose [6]
- Fewer side-effects compared with other doses of administration [1,2,6,7,8]
- Less sedation and constipation resulting in increased quality of life [7]
- Minimal likelihood of opioid addiction or tolerance [9]
- Reduced oral medication intake
- Significant reduction in oral medication intake in 88 patients (63% with
FBS)
who had experienced chronic pain for 9.8 years [10]
References
1. Paice J. J Pain Symptom Manage 1996;
11:71-80
2. Winkelmuller M. J Neurosurg 1996; 85:458-467
3. Tutak V. South Med J 1996; 89:295-300
4. Mueller-Schwefe G. Neuromodulation 1999; 2:77-84
5. Ohnmeiss DD. Spine J 2001; 1:358-363
6. Krames ES. J Pain Symptom Manage 1996; 11:333-352
7. Gianino JM. Practical Patient Management 1996:127-154
8. Naumann C. Neuromodulation 1999; 2:92-107
9. Portenoy RK. J Pain Symptom Manage 1997; 14:S27-35
10. Roberts. Eur J Pain 2001; 5(A):353-361
|
